Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Karyopharm Therapeutics Inc

Clinical trials sponsored by Karyopharm Therapeutics Inc, explained in plain language.

Karyopharm Therapeutics Inc KPTI NASDAQ

Develops nuclear transport modulators for cancer treatment.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet finished but already full! 6 Completed 1

New pill aims to keep endometrial cancer at bay after chemo

Disease control Completed

This Phase 3 trial tested whether taking the drug selinexor as a maintenance pill after chemotherapy can help delay cancer progression in people with advanced or recurrent endometrial cancer. 263 participants who had responded to initial chemo were randomly assigned to receive ei…

Phase: PHASE3 • Sponsor: Karyopharm Therapeutics Inc • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC